PMID: 6183241Jan 1, 1982Paper

Mapping, quantitative distribution and origin of substance p- and VIP-containing nerves in the uvea of guinea pig eye

G TerenghiS R Bloom


VIP- and substance P-like immunoreactivities were found in considerable concentrations (VIP: 17.3 +/- 4.8 pmol/g, mean +/- SEM; substance P:11.1 +/- 1.8 pmol/g) in the uveal portion of the guinea pig eye. Immunocytochemistry localised these two regulatory peptides to nerve fibres found principally in a plexus in the iris (substance P) and in an extensive network surrounding the blood vessels of the choroid (VIP). A remarkable anatomical demarcation of the two types of peptide-containing nerves was established by the staining of substance P-containing nerves, which stops at the level of the ciliary body. This uveal area is known to be involved in the ocular responses to nociceptive stimuli. At the ultrastructural level, immunoreactivity for both peptides was localised to distinct subpopulations of p-type nerves, distinguishable by the size of their large dense-cored vesicles. Those immunoreactive for VIP were significantly larger (p less than 0.0005) than those immunoreactive for substance P (95 +/- 7 nm and 82 +/- 9 nm respectively; mean +/- SD). Interruption of the trigeminal pathway produced a remarkable decrease of substance P immunoreactivity in the anterior portion of the uvea (9.1 +/- 1.5 pmol/g, mean +/- SEM, control; 5....Continue Reading


Nov 1, 1978·Gut·S J Mitchell, S R Bloom
Apr 1, 1976·Journal of Neurocytology·R D Cook, G Burnstock
Dec 1, 1974·The Journal of Cell Biology·R M SteinmanZ A Cohn
Aug 1, 1974·Immunochemistry·E L RomanoN C Hughes-Jones
Jan 1, 1974·Archives of Toxicology·E ReinerV Simeon
Oct 1, 1967·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A El-Badawi, E A Schenk
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·T YamadaW Stell
Apr 10, 1980·Nature·T HökfeltM Schultzberg
Jan 1, 1980·Neuroscience·M Del Fiacco, A C Cuello
Mar 1, 1980·Experimental Eye Research·J M ButlerW G Unger
Jan 1, 1980·Neuroscience·I W ChubbG H White
May 29, 1981·Neuroscience Letters·A MillerI W Chubb
Jan 1, 1980·Critical Reviews in Clinical Laboratory Sciences·R A Rush, L B Geffen
Jan 1, 1981·Toxicology·E W Van SteeM P Moorman
Feb 1, 1980·Acta Physiologica Scandinavica·A L NilssonP A Oberg
Jul 18, 1954·Acta Physiologica Scandinavica·H DUNERB PERNOW
Aug 1, 1978·Neuroscience Letters·M LindvallF Sundler

❮ Previous
Next ❯


Jul 15, 1987·Experientia·R A StoneA M Laties
Jul 15, 1987·Experientia·J Wharton, S Gulbenkian
Jan 1, 1990·Pharmacology & Therapeutics·M C MioneG Burnstock
Jan 1, 1991·Journal of the Autonomic Nervous System·C E HillF R Edwards
Nov 21, 1983·Neuroscience Letters·G TerenghiS R Bloom
Mar 1, 1985·Neuroscience·P K MulderryS R Bloom
Jul 1, 1984·The Journal of Laryngology and Otology·J Ylikoski
Jan 1, 1988·Eye·W G Unger, J M Butler
Jan 1, 1985·Journal of Ocular Pharmacology·W G UngerS R Bloom
Jan 1, 1990·Journal of Ocular Pharmacology·W G Unger
Aug 1, 1984·Acta Physiologica Scandinavica·S F Nilsson, A Bill
Apr 30, 1992·Annals of the New York Academy of Sciences·W G Unger
Feb 24, 2001·Anatomia, histologia, embryologia·C CavallottiE Pacella
Jan 1, 1985·Critical Reviews in Clinical Laboratory Sciences·J BallestaJ M Polak
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·J M AllenS R Bloom
Oct 15, 1990·The Journal of Comparative Neurology·S Kuchiiwa
Jan 1, 1990·Urology·J M AllenS R Bloom
Dec 1, 1984·Experimental Eye Research·R N Williams, P Bhattacherjee

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.